Senate finds UnitedHealth used ‘aggressive strategies’ in Medicare Advantage
Elizabeth Casolo / beckershospitalreview - UnitedHealth Group leveraged “aggressive strategies” to get higher-paying Medicare Advantage diagnoses, according to a Jan. 12 Senate report that Becker’s viewed. The Wall Street Journal initially covered the news. Senate Judiciary Chair Chuck Grassley, R…
AI Summary: A Senate investigation has alleged that UnitedHealth Group employed aggressive strategies to trigger more diagnoses, thereby boosting its reimbursements under Medicare Advantage. The revelations—based on thousands of pages of documentation—raise serious concerns about insurer practices and regulatory scrutiny in the Medicare market.
Merck Could Strike 30 Billion Deal for Revolution Medicines
oncodaily - According to the Financial Times, Merck is in talks to acquire Revolution Medicines, a Redwood City, California-based cancer drug developer, in a deal that could value the company at roughly […]
AI Summary: Merck is reportedly in advanced talks to acquire Revolution Medicines—a Redwood City–based cancer drug developer—in a deal that could be worth around $30 billion. A separate report adds speculative color, reinforcing market buzz about this strategic move in oncology.
Pomelo Care banks $92M to expand virtual women's health, pediatric care services
fiercehealthcare - Pomelo Care banked $92 million in series C funding as it expands beyond maternity care to to more broadly serve women's and children's health needs.
AI Summary: In a bold move that underscores investor confidence, Pomelo Care has raised $92 million in a Series C round. The funding is set to power an expansion beyond maternity care into comprehensive virtual women’s and pediatric health services—proving that when it comes to disruptive healthcare innovation, sometimes the numbers do all the talking.
New US diet guidelines push whole foods, meat and dairy
medicalxpress - The federal government has released new dietary guidelines that shift how Americans are urged to eat.
AI Summary: The federal government has unveiled a major revision in its dietary guidelines—urging Americans to favor whole foods such as lean meats, dairy and protein sources while cutting ultraprocessed items. This unexpected pivot in nutritional policy is sparking conversations about what “healthy eating” will really mean moving forward.
New Jersey system to join RWJBarnabas
Kristin Kuchno / beckershospitalreview - West Orange, N.J.-based RWJBarnabas Health and Englewood (N.J.) Health have signed a definitive agreement under which Englewood would become part of RWJBarnabas Health. The transaction is subject to state and federal regulatory approvals, according to a J…
AI Summary: A definitive agreement has been reached for Englewood Health to become part of West Orange–based RWJBarnabas Health, signaling a major consolidation in the New Jersey market. The merger is expected to drive significant investment in regional hospital networks and overcome previous regulatory hurdles, marking a new phase in local healthcare integration.
21,000 New York nurses to launch strike Jan. 12
fiercehealthcare - Twelve private sector hospitals in New York City and three in Long Island could see nurses walk off the job if no new contract deal is reached. It would be the largest nurse strike in New York City's history.
AI Summary: Reports indicate that while a large contingent of New York nurses – reportedly 21,000 – was poised to strike on January 12, negotiations at seven hospitals have led to tentative agreements that cancelled the planned walkout. Conflicting reports highlight the volatile nature of labor actions in the region.
Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals
Frank Vinluan / medcitynews - Aktis Oncology’s IPO will support a pipeline of “miniprotein” radioconjugates that could offer advantages over other targeted radiation cancer treatments. In addition to its internal pipeline, Aktis has a discovery partnership with Eli Lilly. The post Akt…
AI Summary: Aktis Oncology’s debut on the public market raised $318M, buoyed by a 25% first‐day bounce. The IPO not only generated strong investor enthusiasm for biotech in 2026 but also signals the company’s ambitious plans to extend its portfolio of innovative miniprotein radioconjugates for targeted cancer therapy.
Nestlé recalls baby formula over toxin risk
medicalxpress - Nestlé has announced a global recall of some baby formula products, saying they may contain a toxin that can cause food poisoning in infants.
AI Summary: Nestlé has initiated a global recall of certain baby formula products after detecting potential toxin contamination that may cause food poisoning in infants. Affected lots are being removed from retail shelves while regulators and the company work to confirm the contamination’s extent and ensure consumer safety.
House approves 3-year ACA subsidy extension
Andrew Cass / beckershospitalreview - The House of Representatives voted to extend the ACA enhanced tax credits that expired at the end of 2025 for three years, which now heads to the Senate. The 230-196 vote followed a Democrat-led discharge petition that reached the required 218 representat…
AI Summary: Multiple reports reveal that lawmakers are urgently working to extend enhanced ACA tax credits beyond 2025. The House has approved a three‐year extension to guarantee affordable coverage, as Congress debates renewing these critical subsidies for millions of Americans.
OpenAI Launches ChatGPT Health: 5 Things to Know
Katie Adams / medcitynews - OpenAI announced a new dedicated platform for health conversations. The company said the new offering is not intended for medical diagnosis or treatment — but rather to provide support for personal health navigation.The post OpenAI Launches ChatGPT Health…
AI Summary: OpenAI has rolled out ChatGPT Health, a dedicated platform enabling health‐focused conversations by integrating data from health apps and medical records. Although not intended for diagnosis, the move sparks wry remarks as the tech giant ventures boldly into sensitive, regulated health terrain.
RFK Jr.'s CDC whacks 6 vaccines from childhood recommendation list after opaque monthlong review
fiercehealthcare - The Centers for Disease Control and Prevention (CDC) has upended the immunization schedule for children in the United States, eliminating six of the 17 vaccines that were previously recommended to protect them from disease.
AI Summary: In an unexpected twist to the longstanding immunization program, the CDC has eliminated six previously universal childhood vaccines following a monthlong review—sparking debates and eyebrow raises among healthcare officials. The policy change now tailors recommendations to higher-risk groups while shifting away from a one‐size‐fits‐all approach.
UK starts ban on junk food ads on daytime TV and online
medicalxpress - New regulations come into force Monday in Britain banning daytime TV and online adverts for so-called junk foods, in what the government calls a "world-leading action" to tackle childhood obesity.
AI Summary: British regulators have implemented new rules banning junk food advertisements on daytime TV and online platforms. The measures—targeting products like soft drinks, chocolate, pizza, and ice cream—are part of a government drive to curb unhealthy food marketing and protect public health, especially among younger audiences.
FDA rejects Corcept’s cortisol-targeting drug for Cushing’s syndrome
Ayisha Sharma / endpoints - Corcept Therapeutics failed to secure US approval for its drug candidate as a hormonal disorder treatment. The FDA rejected Corcept’s selective cortisol modulator relacorilant for Cushing’s syndrome, according to a company
AI Summary: Corcept Therapeutics has hit a regulatory roadblock as the FDA rejected its cortisol‐targeting relacorilant, intended for hormonal disorders. The decision forces the company to reassess its strategy, highlighting the challenges inherent in advancing novel hormonal therapies amid strict regulatory scrutiny.
Low-dose peanut therapy shown to protect children with peanut allergies
medicalxpress - Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection against peanuts, finds a new study led by The Hospital for Sick Children (SickKids) and Montreal Children's Hospital.
AI Summary: Emerging study results indicate that administering lower doses of peanut oral immunotherapy can build effective resistance in children with peanut allergies while minimizing adverse side effects. This finding could lead to safer, more accessible treatment protocols that transform current clinical practices and improve overall patient outcomes for pediatric allergy management.
Intratumoral Bacterial Burden Drives Immunotherapy Resistance in Head and Neck Cancer
oncodaily - Immune checkpoint blockade (ICB) benefits only a subset of patients with head and neck squamous cell carcinoma (HNSCC), and commonly used biomarkers (PD-L1, TMB) remain imperfect in this setting. This […]
AI Summary: Researchers reveal that an increased bacterial burden within head and neck tumors may undermine the efficacy of immune checkpoint blockade treatments. Detailed investigations indicate that intratumoral bacteria could be a pivotal factor in treatment resistance, opening new avenues for overcoming these challenges in managing advanced head and neck cancers.
Maimonides Health to merge with NYC Health + Hospitals supported by $2.2B state grant
fiercehealthcare - Brooklyn, New York-based Maimonides Health is merging with New York City's public health system NYC Health + Hospitals, the organizations announced Monday.
AI Summary: Brooklyn-based Maimonides Health is merging with New York City’s public health system, bolstered by a $2.2 billion state grant. The integration is expected to streamline services and strengthen healthcare delivery in the region, ultimately broadening patient access and improving community care.
Judge blocks 340B rebate pilot program
Ella Jeffries / beckershospitalreview - A federal judge granted a temporary restraining order blocking the Department of Health and Human Services from launching its 340B Rebate Model Pilot Program, which was scheduled to begin Jan. 1, 2026. U.S. District Judge Lance Walker of the District of M…
AI Summary: A federal judge has temporarily halted the rollout of a 340B rebate pilot program designed to reshape drug pricing ahead of its January start. The ruling challenges the current administration’s approach to reforming pricing models, casting uncertainty on the initiative’s future.
Advocates Applaud DEA’s Fourth Extension of Remote Prescribing Flexibilities
Marissa Plescia / medcitynews - The DEA extended telemedicine prescribing flexibilities for controlled substances through the end of 2026, drawing praise from telehealth advocates who are urging a permanent solution.The post Advocates Applaud DEA’s Fourth Extension of Remote Prescribing…
AI Summary: The Drug Enforcement Administration has extended telemedicine prescribing flexibilities for controlled substances through 2026, maintaining the COVID-era approach. Telehealth advocates are cheering the move as it cements remote care as a long-term fixture, even as regulators and critics continue debating its broader safety implications.
Foods with healthy-sounding buzzwords could be hiding added sugar in plain sight
medicalxpress - Many consumers feel pride in avoiding the glazed pastries in the supermarket and instead opting for "all natural" granola that comes packed with extra protein. Same goes for low-fat yogurts "made with real fruit," "organic" plant-based milks and bottled "…
AI Summary: Investigative posts reveal that foods flaunting “all‐natural” or “healthy” buzzwords can secretly pack in a surprising amount of added sugars, leaving consumers to wonder if their guilt‐free choices are anything but sweet. A reminder that not every label is as wholesome as it sounds.
Johns Hopkins Hospital names associate chief medical officer
Ella Jeffries / beckershospitalreview - Baltimore-based Johns Hopkins Hospital has named Kavita Sharma, MD, as associate chief medical officer, effective Jan. 6. Dr. Sharma announced her new role in a Dec. 22 post on X, writing that she is “grateful for patients who allow us the privilege of ca…
AI Summary: Johns Hopkins Hospital in Baltimore has announced that Dr. Kavita Sharma will serve as its new associate chief medical officer, effective January 6. Both reports confirm the leadership change as the institution aims to further strengthen its clinical operations and strategic direction.